Effects of Abiraterone Acetate on Chronic Kidney Disease in 2 Patients With Metastatic Castration-resistant Prostate Cancer

被引：3
|
作者：
Francini, Edoardo [1 ]
Petrioli, Roberto [3 ]
Fiaschi, Anna Ida [2 ]
Laera, Letizia [3 ]
Roviello, Giandomenico [3 ]
机构：
[1] Univ Rome, Policlin Umberto Hosp 1, Med Oncol Unit, Rome, Italy
[2] Univ Siena, Pharmacol Unit, I-53100 Siena, Italy
[3] Univ Siena, Med Oncol Unit, I-53100 Siena, Italy
来源：
MEDICINE | 2014年 / 93卷 / 27期
关键词：
INCREASED SURVIVAL; IMMUNOTHERAPY; MITOXANTRONE; PREDNISONE; CYP17;
D O I：
10.1097/MD.0000000000000163
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prostate cancer is the second leading cause of cancer-related death in men in most Western countries. In this report, we present 2 cases of metastatic castration-resistant prostate cancer and chronic kidney disease. Both patients underwent and developed clinical resistance to androgen-deprivation therapy. Subsequently, the patients were treated with the conventional chemotherapeutic approach, which resulted in the worsening of renal function and performance status. Therefore, we opted for treatment with abiraterone acetate, and the patients exhibited improvements in renal function with good response of the disease.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
    Chi, Kim N.
    Rathkopf, Dana
    Smith, Matthew R.
    Efstathiou, Eleni
    Attard, Gerhardt
    Olmos, David
    Lee, Ji Youl
    Small, Eric J.
    Gomes, Andrea J. Pereira De Santana
    Roubaud, Guilhem
    Saad, Marniza
    Zurawski, Bogdan
    Sakalo, Valerii
    Mason, Gary E.
    Francis, Peter
    Ms, George Wang
    Wu, Daphne
    Diorio, Brooke
    Lopez-Gitlitz, Angela
    Sandhu, Shahneen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3339 - +
  • [2] A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer
    Clayton, Ravinder
    Wu, Jackson
    Heng, Daniel Y.
    North, Scott A.
    Emmenegger, Urban
    Hotte, Sebastien
    Chi, Kim
    Zielinski, Rob
    Al-Shamsi, Humaid
    Chen, Leo
    Eigl, Bernhard
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (9-10): : E583 - E590
  • [3] Abiraterone Acetate, A Novel Adrenal Inhibitor in Metastatic Castration-Resistant Prostate Cancer
    Salem, Mohamed
    Garcia, Jorge A.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (02) : 92 - 96
  • [4] Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate
    Thomsen, Frederik Birkebaek
    Roder, Martin Andreas
    Rathenborg, Per
    Brasso, Klaus
    Borre, Michael
    Iversen, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (03) : 268 - 275
  • [5] Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer
    Beardo-Villar, P.
    Ledo-Cepero, M. J.
    Gavira-Moreno, R.
    Soto-Delgado, M.
    Soto-Vittalba, J.
    Alvarez-Ossorio, J. L.
    Juarez-Soto, A.
    ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (05): : 339 - 345
  • [6] Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer
    Auchus, Richard J.
    Yu, Margaret K.
    Nguyen, Suzanne
    Mundle, Suneel D.
    ONCOLOGIST, 2014, 19 (12) : 1231 - 1240
  • [7] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [8] The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
    Onal, Cem
    Sedef, Ali Murat
    Kose, Fatih
    Oymak, Ezgi
    Guler, Ozan Cem
    Sumbul, Ahmet Taner
    Aksoy, Sercan
    Yildirim, Berna Akkus
    Besen, Ali Ayberk
    Muallaoglu, Sadik
    Mertsoylu, Huseyin
    Ozyigit, Gokhan
    FUTURE ONCOLOGY, 2019, 15 (13) : 1469 - 1479
  • [9] Outcomes with Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Who Have Poor Performance Status
    Azad, Arun A.
    Eigl, Bernhard J.
    Leibowitz-Amit, Raya
    Lester, Renee
    Kollmannsberger, Christian
    Murray, Nevin
    Clayton, Ravinder
    Heng, Daniel Y. C.
    Joshua, Anthony M.
    Chi, Kim N.
    EUROPEAN UROLOGY, 2015, 67 (03) : 441 - 447
  • [10] Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (18) : 2077 - 2091
12345